| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | MEP1B ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL2 | 3.29e-19 | 120 | 75 | 15 | GO:0004222 |
| GeneOntologyMolecularFunction | metallopeptidase activity | MEP1B ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL2 | 8.12e-16 | 200 | 75 | 15 | GO:0008237 |
| GeneOntologyMolecularFunction | endopeptidase activity | MEP1B ADAMTS12 ADAMTS10 TMPRSS13 PAMR1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 CAPN7 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL2 CAPN10 | 1.36e-15 | 430 | 75 | 19 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | MEP1B ADAMTS12 ADAMTS10 TMPRSS13 PAMR1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 CAPN7 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL2 CAPN10 | 2.46e-12 | 654 | 75 | 19 | GO:0008233 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.78e-06 | 188 | 75 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 1.39e-05 | 2 | 75 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | calcium ion binding | FBN2 CELSR3 HMCN1 MEGF6 MEGF8 PAMR1 GNPTAB LTBP1 LTBP3 AGRN NOTCH3 STAB1 | 2.12e-05 | 749 | 75 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 4.17e-05 | 3 | 75 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.24e-04 | 26 | 75 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.64e-04 | 73 | 75 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | microfibril binding | 2.07e-04 | 6 | 75 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.83e-03 | 17 | 75 | 2 | GO:0004198 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS12 ADAMTS10 HMCN1 TIE1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 WNT3A ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 6.80e-17 | 377 | 75 | 19 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS12 ADAMTS10 HMCN1 TIE1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 WNT3A ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 7.15e-17 | 378 | 75 | 19 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS12 ADAMTS10 HMCN1 TIE1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 WNT3A ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 7.50e-17 | 379 | 75 | 19 | GO:0045229 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 7.79e-05 | 4 | 75 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | axon guidance | 7.95e-05 | 285 | 75 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.12e-05 | 286 | 75 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | artery development | 1.24e-04 | 133 | 75 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 1.27e-04 | 27 | 75 | 3 | GO:0032331 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 1.30e-04 | 5 | 75 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.70e-04 | 76 | 75 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | aorta development | 2.07e-04 | 80 | 75 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.08e-04 | 566 | 75 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ADAMTS12 FBN2 MEGF8 ADAMTS3 ADAMTS7 WNT3A PDGFD LTBP1 LTBP3 ECSIT ADAMTSL2 | 2.40e-04 | 850 | 75 | 11 | GO:0071363 |
| GeneOntologyBiologicalProcess | positive regulation of pigment cell differentiation | 2.71e-04 | 7 | 75 | 2 | GO:0050942 | |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 2.71e-04 | 7 | 75 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 3.02e-04 | 36 | 75 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ADAMTS12 FBN2 MEGF8 TIE1 ADAMTS3 EFS WNT3A PDGFD LTBP1 LTBP3 ECSIT AGRN ADAMTSL2 | 3.18e-04 | 1186 | 75 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | response to growth factor | ADAMTS12 FBN2 MEGF8 ADAMTS3 ADAMTS7 WNT3A PDGFD LTBP1 LTBP3 ECSIT ADAMTSL2 | 3.32e-04 | 883 | 75 | 11 | GO:0070848 |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 3.60e-04 | 8 | 75 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | NSMF CELSR3 MEGF8 SEMA5B WNT3A ADGRB1 POTEJ LMO4 AGRN NOTCH3 | 3.65e-04 | 748 | 75 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | pigment cell differentiation | 4.14e-04 | 40 | 75 | 3 | GO:0050931 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 4.44e-04 | 175 | 75 | 5 | GO:0016525 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental pigmentation | 4.62e-04 | 9 | 75 | 2 | GO:0048087 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 4.62e-04 | 9 | 75 | 2 | GO:0050932 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 4.79e-04 | 178 | 75 | 5 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 5.04e-04 | 180 | 75 | 5 | GO:1901343 | |
| GeneOntologyBiologicalProcess | axon development | 5.22e-04 | 642 | 75 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | secretion of lysosomal enzymes | 5.76e-04 | 10 | 75 | 2 | GO:0033299 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | NSMF CELSR3 MEGF8 SEMA5B WNT3A ADGRB1 POTEJ LMO4 AGRN NOTCH3 | 6.29e-04 | 802 | 75 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 7.02e-04 | 11 | 75 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | NSMF CELSR3 MEGF8 SEMA5B WNT3A ADGRB1 POTEJ LMO4 AGRN NOTCH3 | 7.39e-04 | 819 | 75 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | NSMF CELSR3 MEGF8 SEMA5B WNT3A ADGRB1 POTEJ LMO4 AGRN NOTCH3 | 7.89e-04 | 826 | 75 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CACNA1S FBN2 TIE1 ADAMTS9 WNT3A WNT10B ADGRB1 ADAMTS5 LMO4 ECSIT PGK1 VPS13B NOTCH3 STAB1 | 8.19e-04 | 1483 | 75 | 14 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | ADAMTS12 RETN GPATCH3 TIE1 ADAMTS7 ADAMTS9 WNT3A WNT10B ADGRB1 ADAMTS18 LTBP3 ADAMTS5 PGK1 STAB1 | 8.46e-04 | 1488 | 75 | 14 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of locomotion | FBN2 RETN NSMF MEGF8 TIE1 SEMA5B ADAMTS9 CAPN7 WNT3A PDGFD ADGRB1 LMO4 AGRN | 9.18e-04 | 1327 | 75 | 13 | GO:0040012 |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 9.92e-04 | 13 | 75 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 9.92e-04 | 13 | 75 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | pigmentation | 1.12e-03 | 125 | 75 | 4 | GO:0043473 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.12e-03 | 215 | 75 | 5 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.12e-03 | 215 | 75 | 5 | GO:0071773 | |
| GeneOntologyBiologicalProcess | bone trabecula formation | 1.15e-03 | 14 | 75 | 2 | GO:0060346 | |
| GeneOntologyBiologicalProcess | spinal cord association neuron differentiation | 1.15e-03 | 14 | 75 | 2 | GO:0021527 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.17e-03 | 445 | 75 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 1.23e-03 | 58 | 75 | 3 | GO:0007520 | |
| GeneOntologyBiologicalProcess | developmental pigmentation | 1.23e-03 | 58 | 75 | 3 | GO:0048066 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 1.30e-03 | 59 | 75 | 3 | GO:0032330 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 1.33e-03 | 15 | 75 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | regulation of developmental pigmentation | 1.33e-03 | 15 | 75 | 2 | GO:0048070 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 ADAMTS10 FBN2 PRG3 HMCN1 MEGF6 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN MUC5B LTBP1 LTBP3 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 ADAMTSL2 | 1.20e-20 | 656 | 75 | 26 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 ADAMTS10 FBN2 PRG3 HMCN1 MEGF6 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN MUC5B LTBP1 LTBP3 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 ADAMTSL2 | 1.30e-20 | 658 | 75 | 26 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 FBN2 PRG3 HMCN1 MEGF6 ADAMTS3 ADAMTS9 SPON1 ADAMTS17 ADAMTS20 PAPLN LTBP1 LTBP3 ADAMTS5 ADAM11 AGRN ADAMTSL4 | 4.37e-12 | 530 | 75 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 1.24e-05 | 13 | 75 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.88e-04 | 332 | 75 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | perikaryon | 1.24e-03 | 223 | 75 | 5 | GO:0043204 | |
| HumanPheno | Ovoid vertebral bodies | 3.03e-05 | 34 | 28 | 4 | HP:0003300 | |
| HumanPheno | Lens dislocation | 7.78e-05 | 43 | 28 | 4 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 7.78e-05 | 43 | 28 | 4 | HP:0001083 | |
| HumanPheno | Joint stiffness | 8.09e-05 | 202 | 28 | 7 | HP:0001387 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 1.20e-04 | 215 | 28 | 7 | HP:0031650 | |
| HumanPheno | Abnormal heart valve morphology | ADAMTS10 FBN2 MEGF8 GNPTAB ADAMTS17 MUC5B LTBP1 LTBP3 VPS13B NOTCH3 ADAMTSL2 | 1.50e-04 | 588 | 28 | 11 | HP:0001654 |
| MousePheno | abnormal appendicular skeleton morphology | ADAMTS10 CACNA1S FBN2 MEGF8 ADAMTS6 SPON1 GNPTAB ADAMTS17 LTBP1 LTBP3 LMO4 ADAMTSL3 ADAMTSL2 CAPN10 | 4.20e-05 | 896 | 64 | 14 | MP:0009250 |
| MousePheno | abnormal skeletal muscle mass | 5.97e-05 | 149 | 64 | 6 | MP:0004817 | |
| MousePheno | abnormal skin morphology | ADAMTS10 CACNA1S FBN2 PRG3 TMPRSS13 MEGF8 TIE1 ADAMTS3 ADAMTS9 GNPTAB TMEM79 ADAMTS17 ADAMTS20 MUC5B LTBP3 WDFY3 LMO4 VPS13B | 6.20e-05 | 1455 | 64 | 18 | MP:0002060 |
| Domain | TSP_1 | ADAMTS12 ADAMTS10 HMCN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADGRB1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 5.36e-36 | 63 | 75 | 21 | PF00090 |
| Domain | TSP1 | ADAMTS12 ADAMTS10 HMCN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADGRB1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.17e-35 | 65 | 75 | 21 | SM00209 |
| Domain | TSP1_rpt | ADAMTS12 ADAMTS10 HMCN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADGRB1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.17e-35 | 65 | 75 | 21 | IPR000884 |
| Domain | TSP1 | ADAMTS12 ADAMTS10 HMCN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADGRB1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.17e-35 | 65 | 75 | 21 | PS50092 |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL4 ADAMTSL2 | 1.22e-31 | 23 | 75 | 15 | IPR010294 |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL4 ADAMTSL2 | 1.22e-31 | 23 | 75 | 15 | PF05986 |
| Domain | Peptidase_M12B_ADAM-TS | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 ADAMTS14 ADAMTSL3 ADAMTSL2 | 3.25e-31 | 24 | 75 | 15 | IPR013273 |
| Domain | PLAC | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS17 ADAMTS18 PAPLN ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 6.27e-28 | 19 | 75 | 13 | PS50900 |
| Domain | PLAC | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS17 ADAMTS18 PAPLN ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 6.27e-28 | 19 | 75 | 13 | IPR010909 |
| Domain | Peptidase_M12B_N | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 1.76e-22 | 39 | 75 | 13 | IPR002870 |
| Domain | Pep_M12B_propep | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 1.76e-22 | 39 | 75 | 13 | PF01562 |
| Domain | DISINTEGRIN_1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 2.60e-22 | 40 | 75 | 13 | PS00427 |
| Domain | Reprolysin | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 2.60e-22 | 40 | 75 | 13 | PF01421 |
| Domain | ADAM_MEPRO | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 2.60e-22 | 40 | 75 | 13 | PS50215 |
| Domain | DISINTEGRIN_2 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 2.60e-22 | 40 | 75 | 13 | PS50214 |
| Domain | Peptidase_M12B | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 2.60e-22 | 40 | 75 | 13 | IPR001590 |
| Domain | Disintegrin_dom | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 3.80e-22 | 41 | 75 | 13 | IPR001762 |
| Domain | EGF_3 | MEP1B ATRN CNTNAP3B FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 5.80e-20 | 235 | 75 | 19 | PS50026 |
| Domain | EGF | MEP1B ATRN CNTNAP3B FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 5.80e-20 | 235 | 75 | 19 | SM00181 |
| Domain | MetalloPept_cat_dom | MEP1B ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 1.16e-19 | 81 | 75 | 14 | IPR024079 |
| Domain | - | MEP1B ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 1.16e-19 | 81 | 75 | 14 | 3.40.390.10 |
| Domain | EGF-like_dom | MEP1B ATRN CNTNAP3B FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 1.75e-19 | 249 | 75 | 19 | IPR000742 |
| Domain | EGF_1 | MEP1B ATRN CNTNAP3B FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 2.74e-19 | 255 | 75 | 19 | PS00022 |
| Domain | PLAC | ADAMTS10 ADAMTS6 ADAMTS16 ADAMTS17 ADAMTS18 PAPLN ADAMTSL3 ADAMTSL4 ADAMTSL2 | 3.25e-19 | 14 | 75 | 9 | PF08686 |
| Domain | EGF_2 | MEP1B ATRN CNTNAP3B FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 5.69e-19 | 265 | 75 | 19 | PS01186 |
| Domain | ZINC_PROTEASE | MEP1B ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 | 1.97e-18 | 98 | 75 | 14 | PS00142 |
| Domain | EGF-like_CS | MEP1B ATRN FBN2 CELSR3 HMCN1 MEGF6 MEGF8 TIE1 PAMR1 CNTNAP3 TENM1 LTBP1 LTBP3 ADAM11 NAGPA AGRN NOTCH3 STAB1 | 1.08e-17 | 261 | 75 | 18 | IPR013032 |
| Domain | EGF | MEP1B ATRN CELSR3 HMCN1 MEGF6 TIE1 PAMR1 CNTNAP3 LTBP1 NAGPA AGRN NOTCH3 STAB1 | 2.83e-15 | 126 | 75 | 13 | PF00008 |
| Domain | EGF_CA | FBN2 CELSR3 HMCN1 MEGF6 MEGF8 PAMR1 LTBP1 LTBP3 AGRN NOTCH3 STAB1 | 2.01e-12 | 122 | 75 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FBN2 CELSR3 HMCN1 MEGF6 MEGF8 PAMR1 LTBP1 LTBP3 AGRN NOTCH3 STAB1 | 2.41e-12 | 124 | 75 | 11 | IPR001881 |
| Domain | EGF_extracell | 9.97e-11 | 60 | 75 | 8 | IPR013111 | |
| Domain | EGF_2 | 9.97e-11 | 60 | 75 | 8 | PF07974 | |
| Domain | CYSTEINE_SWITCH | ADAMTS12 ADAMTS7 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS14 | 2.55e-10 | 41 | 75 | 7 | PS00546 |
| Domain | Pept_M10_metallopeptidase | ADAMTS12 ADAMTS7 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS14 | 3.63e-10 | 43 | 75 | 7 | IPR001818 |
| Domain | Growth_fac_rcpt_ | 6.43e-10 | 156 | 75 | 10 | IPR009030 | |
| Domain | Laminin_EGF | 5.06e-09 | 35 | 75 | 6 | PF00053 | |
| Domain | EGF_Lam | 5.06e-09 | 35 | 75 | 6 | SM00180 | |
| Domain | ASX_HYDROXYL | 6.38e-09 | 100 | 75 | 8 | PS00010 | |
| Domain | Laminin_EGF | 8.53e-09 | 38 | 75 | 6 | IPR002049 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.01e-08 | 106 | 75 | 8 | IPR000152 | |
| Domain | EGF_CA | 5.28e-08 | 86 | 75 | 7 | PF07645 | |
| Domain | EGF_LAM_2 | 1.20e-07 | 30 | 75 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 1.20e-07 | 30 | 75 | 5 | PS01248 | |
| Domain | EGF_Ca-bd_CS | 1.22e-07 | 97 | 75 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.40e-07 | 99 | 75 | 7 | PS01187 | |
| Domain | TB | 2.15e-06 | 7 | 75 | 3 | PF00683 | |
| Domain | cEGF | 3.35e-06 | 26 | 75 | 4 | IPR026823 | |
| Domain | cEGF | 3.35e-06 | 26 | 75 | 4 | PF12662 | |
| Domain | - | 3.43e-06 | 8 | 75 | 3 | 3.90.290.10 | |
| Domain | ACR | 3.92e-06 | 27 | 75 | 4 | SM00608 | |
| Domain | ADAM_Cys-rich | 3.92e-06 | 27 | 75 | 4 | IPR006586 | |
| Domain | hEGF | 4.56e-06 | 28 | 75 | 4 | PF12661 | |
| Domain | TB | 5.13e-06 | 9 | 75 | 3 | PS51364 | |
| Domain | TB_dom | 5.13e-06 | 9 | 75 | 3 | IPR017878 | |
| Domain | PGLYCERATE_KINASE | 1.59e-05 | 2 | 75 | 2 | PS00111 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.59e-05 | 2 | 75 | 2 | IPR012314 | |
| Domain | Phosphoglycerate_kinase_N | 1.59e-05 | 2 | 75 | 2 | IPR015824 | |
| Domain | GON | 1.59e-05 | 2 | 75 | 2 | PF08685 | |
| Domain | Phosphoglycerate_kinase_CS | 1.59e-05 | 2 | 75 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 1.59e-05 | 2 | 75 | 2 | IPR015901 | |
| Domain | GON | 1.59e-05 | 2 | 75 | 2 | PS51046 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 3.40.50.1270 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 3.40.50.1260 | |
| Domain | PGK | 1.59e-05 | 2 | 75 | 2 | PF00162 | |
| Domain | LAM_G_DOMAIN | 1.60e-05 | 38 | 75 | 4 | PS50025 | |
| Domain | LamG | 2.88e-05 | 44 | 75 | 4 | SM00282 | |
| Domain | CUB | 4.43e-05 | 49 | 75 | 4 | PF00431 | |
| Domain | Phosphoglycerate_kinase | 4.76e-05 | 3 | 75 | 2 | IPR001576 | |
| Domain | CUB | 4.80e-05 | 50 | 75 | 4 | SM00042 | |
| Domain | - | 5.61e-05 | 52 | 75 | 4 | 2.60.120.290 | |
| Domain | CUB | 6.05e-05 | 53 | 75 | 4 | PS01180 | |
| Domain | CUB_dom | 8.06e-05 | 57 | 75 | 4 | IPR000859 | |
| Domain | Laminin_G | 8.63e-05 | 58 | 75 | 4 | IPR001791 | |
| Domain | LNR | 1.58e-04 | 5 | 75 | 2 | PS50258 | |
| Domain | ConA-like_dom | 2.49e-04 | 219 | 75 | 6 | IPR013320 | |
| Domain | PSI | 2.84e-04 | 32 | 75 | 3 | PF01437 | |
| Domain | Plexin_repeat | 2.84e-04 | 32 | 75 | 3 | IPR002165 | |
| Domain | Notch_dom | 3.30e-04 | 7 | 75 | 2 | IPR000800 | |
| Domain | Notch | 3.30e-04 | 7 | 75 | 2 | PF00066 | |
| Domain | NL | 3.30e-04 | 7 | 75 | 2 | SM00004 | |
| Domain | ANK | 5.15e-04 | 251 | 75 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 5.37e-04 | 253 | 75 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.48e-04 | 254 | 75 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.48e-04 | 254 | 75 | 6 | PS50297 | |
| Domain | Laminin_G_2 | 5.52e-04 | 40 | 75 | 3 | PF02210 | |
| Domain | - | 5.79e-04 | 95 | 75 | 4 | 2.60.120.200 | |
| Domain | Ankyrin_rpt | 6.45e-04 | 262 | 75 | 6 | IPR002110 | |
| Domain | PSI | 7.32e-04 | 44 | 75 | 3 | IPR016201 | |
| Domain | PSI | 8.34e-04 | 46 | 75 | 3 | SM00423 | |
| Domain | - | 8.55e-04 | 11 | 75 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 8.55e-04 | 11 | 75 | 2 | IPR023413 | |
| Domain | GAIN_dom_N | 8.55e-04 | 11 | 75 | 2 | IPR032471 | |
| Domain | GAIN | 8.55e-04 | 11 | 75 | 2 | PF16489 | |
| Domain | - | 9.45e-04 | 48 | 75 | 3 | 2.120.10.80 | |
| Domain | EGF_3 | 1.02e-03 | 12 | 75 | 2 | PF12947 | |
| Domain | Calpain_III | 1.02e-03 | 12 | 75 | 2 | IPR022683 | |
| Domain | EGF_dom | 1.02e-03 | 12 | 75 | 2 | IPR024731 | |
| Domain | calpain_III | 1.02e-03 | 12 | 75 | 2 | SM00720 | |
| Domain | C2_III | 1.02e-03 | 12 | 75 | 2 | IPR033883 | |
| Domain | Calpain_domain_III | 1.21e-03 | 13 | 75 | 2 | IPR022682 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.68e-34 | 39 | 56 | 18 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.68e-34 | 39 | 56 | 18 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 NOTCH3 ADAMTSL2 | 1.47e-33 | 68 | 56 | 20 | M27303 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 NOTCH3 ADAMTSL2 | 2.95e-28 | 143 | 56 | 21 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 4.89e-27 | 109 | 56 | 19 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 7.10e-27 | 111 | 56 | 19 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 NOTCH3 ADAMTSL2 | 5.59e-23 | 250 | 56 | 21 | M27554 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBN2 ADAMTS3 ADAMTS9 CAPN7 ADAMTS16 ADAMTS18 LTBP1 LTBP3 ADAMTS5 ADAMTS14 AGRN CAPN10 | 1.68e-09 | 300 | 56 | 12 | M610 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS10 MEGF6 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 DCAF17 ADAMTS18 ADAMTS20 MUC5B LTBP1 ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 4.88e-09 | 1389 | 56 | 22 | MM15307 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | FBN2 MEGF6 ADAMTS3 CAPN7 LTBP1 LTBP3 ADAMTS5 ADAMTS14 AGRN CAPN10 | 6.02e-08 | 258 | 56 | 10 | MM14572 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS10 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADAMTS16 ADAMTS17 DCAF17 ADAMTS18 ADAMTS20 MUC5B LTBP1 ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 8.20e-08 | 1475 | 56 | 21 | M19806 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.27e-06 | 140 | 56 | 7 | M587 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 8.64e-05 | 59 | 56 | 4 | M39886 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.71e-04 | 32 | 56 | 3 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.19e-04 | 37 | 56 | 3 | M27134 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 4.27e-04 | 8 | 56 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.90e-04 | 39 | 56 | 3 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.01e-04 | 44 | 56 | 3 | M26969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.08e-03 | 114 | 56 | 4 | MM14571 | |
| Pathway | WP_CORI_CYCLE | 2.03e-03 | 17 | 56 | 2 | M39604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.54e-03 | 19 | 56 | 2 | M47836 | |
| Pubmed | ADAMTS12 ADAMTS10 HMCN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 ADGRB1 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN ADAMTS5 THSD7B ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 1.24e-39 | 75 | 76 | 21 | 20637190 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | ADAMTS12 ADAMTS10 ADAMTS7 ADAMTS9 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 | 1.75e-19 | 12 | 76 | 8 | 25770910 |
| Pubmed | 2.14e-17 | 10 | 76 | 7 | 11167130 | ||
| Pubmed | 2.10e-11 | 4 | 76 | 4 | 16507336 | ||
| Pubmed | 1.01e-10 | 64 | 76 | 7 | 22261194 | ||
| Pubmed | 1.87e-10 | 16 | 76 | 5 | 30579834 | ||
| Pubmed | 3.15e-10 | 6 | 76 | 4 | 17171436 | ||
| Pubmed | 7.33e-10 | 7 | 76 | 4 | 11867212 | ||
| Pubmed | 1.46e-09 | 8 | 76 | 4 | 12475935 | ||
| Pubmed | 6.87e-09 | 11 | 76 | 4 | 33909046 | ||
| Pubmed | 1.00e-08 | 3 | 76 | 3 | 24753090 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 2.82e-08 | 15 | 76 | 4 | 38871984 | |
| Pubmed | 4.00e-08 | 4 | 76 | 3 | 17342726 | ||
| Pubmed | 4.90e-08 | 17 | 76 | 4 | 10464288 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 6.29e-08 | 18 | 76 | 4 | 35503090 | |
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 1.00e-07 | 5 | 76 | 3 | 29625437 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 29758265 | ||
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 22562232 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MEGF6 MEGF8 EFS LTBP1 LTBP3 AGRN ADAMTSL4 NOTCH3 ADAMTSL2 STAB1 | 3.98e-07 | 560 | 76 | 10 | 21653829 |
| Pubmed | 4.07e-07 | 210 | 76 | 7 | 16537572 | ||
| Pubmed | 5.57e-07 | 8 | 76 | 3 | 21041365 | ||
| Pubmed | 8.34e-07 | 9 | 76 | 3 | 9693030 | ||
| Pubmed | 1.05e-06 | 35 | 76 | 4 | 34108685 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.24e-06 | 248 | 76 | 7 | 24006456 | |
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 1.47e-06 | 38 | 76 | 4 | 18267097 | |
| Pubmed | 1.85e-06 | 167 | 76 | 6 | 22159717 | ||
| Pubmed | 3.55e-06 | 105 | 76 | 5 | 9628581 | ||
| Pubmed | Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene. | 4.71e-06 | 2 | 76 | 2 | 9023984 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31150793 | ||
| Pubmed | Lmo4-resistin signaling contributes to adipose tissue-liver crosstalk upon weight cycling. | 4.71e-06 | 2 | 76 | 2 | 32030835 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25572698 | ||
| Pubmed | Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. | 4.71e-06 | 2 | 76 | 2 | 3453121 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8441629 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23154421 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 2298243 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26807827 | ||
| Pubmed | Selective activation of testis-specific genes in cultured rat spermatogenic cells. | 4.71e-06 | 2 | 76 | 2 | 2166582 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12514189 | ||
| Pubmed | Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. | 4.71e-06 | 2 | 76 | 2 | 20568084 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29137610 | ||
| Pubmed | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | 4.71e-06 | 2 | 76 | 2 | 19098927 | |
| Pubmed | Human phosphoglycerate kinase. I. Crystallization and characterization of normal enzyme. | 4.71e-06 | 2 | 76 | 2 | 5009693 | |
| Pubmed | The family of mouse phosphoglycerate kinase genes and pseudogenes. | 4.71e-06 | 2 | 76 | 2 | 2829366 | |
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 4.71e-06 | 2 | 76 | 2 | 27779234 | |
| Pubmed | Characterization of phosphoglycerate kinase from human spermatozoa. | 4.71e-06 | 2 | 76 | 2 | 1278465 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36810712 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 8662942 | ||
| Pubmed | Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits. | 4.71e-06 | 2 | 76 | 2 | 25190493 | |
| Pubmed | Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. | 4.71e-06 | 2 | 76 | 2 | 26382559 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19836009 | ||
| Pubmed | Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. | 4.71e-06 | 2 | 76 | 2 | 22247065 | |
| Pubmed | 6.29e-06 | 118 | 76 | 5 | 21078624 | ||
| Pubmed | 6.67e-06 | 17 | 76 | 3 | 22183742 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATRN FBN2 CELSR3 MEGF8 GNPTAB CNTNAP3 LTBP1 LTBP3 CERS1 NAGPA AGRN NOTCH3 | 1.10e-05 | 1201 | 76 | 12 | 35696571 |
| Pubmed | 1.11e-05 | 20 | 76 | 3 | 19922873 | ||
| Pubmed | 1.25e-05 | 493 | 76 | 8 | 15368895 | ||
| Pubmed | The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology. | 1.41e-05 | 3 | 76 | 2 | 25863161 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 11741898 | ||
| Pubmed | Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. | 1.41e-05 | 3 | 76 | 2 | 1380672 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30201140 | ||
| Pubmed | Mutations in the lysosomal enzyme-targeting pathway and persistent stuttering. | 1.41e-05 | 3 | 76 | 2 | 20147709 | |
| Pubmed | Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). | 1.41e-05 | 3 | 76 | 2 | 7730318 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 26130485 | ||
| Pubmed | Variants in GNPTAB, GNPTG and NAGPA genes are associated with stutterers. | 1.41e-05 | 3 | 76 | 2 | 29289611 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 1.41e-05 | 3 | 76 | 2 | 29604272 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20301776 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18677313 | ||
| Pubmed | Wnt-10b, uniquely among Wnts, promotes epithelial differentiation and shaft growth. | 1.41e-05 | 3 | 76 | 2 | 18155657 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 14667842 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25643770 | ||
| Pubmed | A role for inherited metabolic deficits in persistent developmental stuttering. | 1.41e-05 | 3 | 76 | 2 | 22884963 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 37169079 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 23562508 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18672106 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10743502 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.50e-05 | 22 | 76 | 3 | 26494785 | |
| Pubmed | 1.72e-05 | 23 | 76 | 3 | 26027930 | ||
| Pubmed | 1.96e-05 | 24 | 76 | 3 | 29791855 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.51e-05 | 26 | 76 | 3 | 34189436 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 12429738 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 18045882 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 15611103 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 20301293 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 18485748 | ||
| Pubmed | ADAMTS-3, -13, -16, and -19 levels in patients with habitual abortion. | 2.82e-05 | 4 | 76 | 2 | 28088271 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 24220035 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 2.82e-05 | 4 | 76 | 2 | 11104663 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 22205175 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 16157329 | ||
| Pubmed | Genetic factors and therapy outcomes in persistent developmental stuttering. | 2.82e-05 | 4 | 76 | 2 | 31003007 | |
| Pubmed | 3.00e-05 | 163 | 76 | 5 | 24316575 | ||
| Pubmed | 3.90e-05 | 30 | 76 | 3 | 16524929 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 3.90e-05 | 30 | 76 | 3 | 32882513 | |
| Pubmed | 4.22e-05 | 175 | 76 | 5 | 28071719 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 4.31e-05 | 31 | 76 | 3 | 11431694 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 4.31e-05 | 31 | 76 | 3 | 31550482 | |
| Pubmed | 4.31e-05 | 31 | 76 | 3 | 25762570 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 19897194 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 11831030 | ||
| Interaction | FBXO2 interactions | ATRN CNTNAP3B FBN2 CELSR3 MEGF8 ADAMTS7 GNPTAB WNT10B CNTNAP3 AGRN NOTCH3 | 3.37e-07 | 411 | 75 | 11 | int:FBXO2 |
| Interaction | IGFL3 interactions | 3.56e-07 | 75 | 75 | 6 | int:IGFL3 | |
| Interaction | CFC1 interactions | 4.40e-07 | 126 | 75 | 7 | int:CFC1 | |
| Interaction | ADAMTS12 interactions | 1.88e-06 | 55 | 75 | 5 | int:ADAMTS12 | |
| Interaction | CBLN4 interactions | 7.85e-06 | 127 | 75 | 6 | int:CBLN4 | |
| Interaction | SLURP1 interactions | 1.61e-05 | 144 | 75 | 6 | int:SLURP1 | |
| Interaction | SDF2L1 interactions | 2.59e-05 | 322 | 75 | 8 | int:SDF2L1 | |
| Interaction | TRGV3 interactions | 5.23e-05 | 55 | 75 | 4 | int:TRGV3 | |
| Interaction | HOXA1 interactions | 5.28e-05 | 356 | 75 | 8 | int:HOXA1 | |
| Interaction | ZFP41 interactions | 6.02e-05 | 57 | 75 | 4 | int:ZFP41 | |
| Interaction | DNASE1L1 interactions | 8.52e-05 | 120 | 75 | 5 | int:DNASE1L1 | |
| Interaction | PRG2 interactions | 9.18e-05 | 285 | 75 | 7 | int:PRG2 | |
| Interaction | NTN5 interactions | 9.47e-05 | 24 | 75 | 3 | int:NTN5 | |
| Interaction | CACNA1A interactions | 9.57e-05 | 123 | 75 | 5 | int:CACNA1A | |
| Interaction | CRIPTO interactions | 1.27e-04 | 69 | 75 | 4 | int:CRIPTO | |
| Interaction | ADAMTS19 interactions | 1.36e-04 | 5 | 75 | 2 | int:ADAMTS19 | |
| Interaction | GPIHBP1 interactions | 1.38e-04 | 133 | 75 | 5 | int:GPIHBP1 | |
| Interaction | FIBIN interactions | 1.42e-04 | 71 | 75 | 4 | int:FIBIN | |
| Interaction | NOTCH2 interactions | 1.74e-04 | 423 | 75 | 8 | int:NOTCH2 | |
| Interaction | CST11 interactions | 1.76e-04 | 75 | 75 | 4 | int:CST11 | |
| Interaction | MBD1 interactions | 1.95e-04 | 77 | 75 | 4 | int:MBD1 | |
| Interaction | FBXO6 interactions | ATRN CNTNAP3B FBN2 MEGF8 ADAMTS7 MUC5B LTBP1 LTBP3 AGRN ADAMTSL4 | 3.13e-04 | 717 | 75 | 10 | int:FBXO6 |
| Interaction | COL6A2 interactions | 3.55e-04 | 90 | 75 | 4 | int:COL6A2 | |
| Interaction | ELSPBP1 interactions | 3.86e-04 | 92 | 75 | 4 | int:ELSPBP1 | |
| Interaction | C1orf54 interactions | 3.98e-04 | 167 | 75 | 5 | int:C1orf54 | |
| Interaction | CRISP2 interactions | 4.43e-04 | 40 | 75 | 3 | int:CRISP2 | |
| Interaction | ADAMTS6 interactions | 4.84e-04 | 9 | 75 | 2 | int:ADAMTS6 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAMTS14 | 1.09e-26 | 19 | 56 | 12 | 50 |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.00e-10 | 13 | 56 | 5 | 685 | |
| GeneFamily | ADAMTS like | 2.87e-09 | 7 | 56 | 4 | 947 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 5.63e-05 | 4 | 56 | 2 | 628 | |
| GeneFamily | Ankyrin repeat domain containing | 1.00e-04 | 242 | 56 | 6 | 403 | |
| GeneFamily | C2 domain containing|Calpains | 9.64e-04 | 15 | 56 | 2 | 975 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.56e-03 | 19 | 56 | 2 | 360 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.15e-03 | 41 | 56 | 2 | 1298 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.36e-02 | 161 | 56 | 3 | 593 | |
| Coexpression | NABA_MATRISOME | MEP1B ADAMTS12 ADAMTS10 FBN2 PRG3 HMCN1 MEGF6 MEGF8 PAMR1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 WNT3A PDGFD WNT10B ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN MUC5B LTBP1 LTBP3 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 ADAMTSL2 | 8.93e-27 | 1008 | 76 | 33 | MM17056 |
| Coexpression | NABA_MATRISOME | MEP1B ADAMTS12 ADAMTS10 FBN2 PRG3 HMCN1 MEGF6 MEGF8 PAMR1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 SPON1 WNT3A PDGFD WNT10B ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 PAPLN MUC5B LTBP1 LTBP3 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 AGRN ADAMTSL4 ADAMTSL2 | 1.57e-26 | 1026 | 76 | 33 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | MEP1B ADAMTS12 ADAMTS10 PAMR1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 7.22e-21 | 238 | 76 | 18 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | MEP1B ADAMTS12 ADAMTS10 PAMR1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS9 ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 9.77e-21 | 242 | 76 | 18 | MM17062 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MEP1B ADAMTS12 ADAMTS10 MEGF6 MEGF8 PAMR1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 WNT3A PDGFD WNT10B ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 2.36e-20 | 738 | 76 | 25 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MEP1B ADAMTS12 ADAMTS10 MEGF6 MEGF8 PAMR1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS9 WNT3A PDGFD WNT10B ADAMTS16 ADAMTS17 ADAMTS18 ADAMTS20 MUC5B ADAMTS5 ADAM11 ADAMTS14 ADAMTSL3 ADAMTSL4 ADAMTSL2 | 3.58e-20 | 751 | 76 | 25 | M5885 |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 7.40e-09 | 89 | 76 | 7 | M40280 | |
| Coexpression | NABA_CORE_MATRISOME | 1.18e-06 | 270 | 76 | 8 | MM17057 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 1.26e-06 | 188 | 76 | 7 | MM1071 | |
| Coexpression | NABA_CORE_MATRISOME | 1.35e-06 | 275 | 76 | 8 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.40e-06 | 191 | 76 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.66e-06 | 196 | 76 | 7 | M3008 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 2.23e-05 | 195 | 76 | 6 | M45684 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 2.63e-05 | 59 | 76 | 4 | M47989 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 1.50e-04 | 173 | 76 | 5 | M2385 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.50e-04 | 92 | 76 | 4 | MM503 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.14e-04 | 40 | 76 | 3 | M5887 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 2.15e-04 | 187 | 76 | 5 | M7123 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 2.31e-04 | 41 | 76 | 3 | M47988 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | ADAMTS12 PAMR1 ADAMTS9 GNPTAB ADAMTS17 LTBP1 WDFY3 AGRN NOTCH3 | 1.02e-06 | 293 | 76 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 |
| CoexpressionAtlas | placenta | FBN2 TIE1 ADAMTS6 ADAMTS9 WNT3A ADAMTS18 ADAMTS5 ADAMTS14 ADAMTSL4 | 4.27e-06 | 349 | 76 | 9 | placenta |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | ADAMTS12 ADAMTS10 ATRN FBN2 HMCN1 PAMR1 SEMA5B ADAMTS6 ADAMTS9 ADAMTS16 LTBP1 LMO4 RNF217 ADAMTSL2 STAB1 | 1.37e-05 | 1166 | 76 | 15 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | MEP1B ADAMTS12 UBR1 PAMR1 ADAMTS3 ADAMTS6 ADAMTS9 GNPTAB ADAMTS17 LTBP1 WDFY3 AGRN NOTCH3 | 1.78e-05 | 905 | 76 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.88e-05 | 354 | 76 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.61e-05 | 281 | 76 | 7 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.61e-05 | 281 | 76 | 7 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_500 | 6.72e-05 | 193 | 76 | 6 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | CNTNAP3B STARD8 TIE1 ADAMTS6 CNTNAP3 ADAMTS18 ADAMTSL3 STAB1 | 1.45e-04 | 428 | 76 | 8 | JC_hmvEC_1000_K4 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-09 | 194 | 76 | 8 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-09 | 195 | 76 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-08 | 178 | 76 | 7 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-08 | 188 | 76 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-08 | 191 | 76 | 7 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-08 | 193 | 76 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.08e-08 | 193 | 76 | 7 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.03e-08 | 199 | 76 | 7 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.21e-08 | 200 | 76 | 7 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.67e-08 | 119 | 76 | 6 | d8fbea9ded96fcc3ebdfb4d28873c563427ce811 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.67e-08 | 119 | 76 | 6 | 9e38f13bf98b9ee44b178300e6f80fd08a006296 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-07 | 174 | 76 | 6 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.92e-07 | 177 | 76 | 6 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.33e-07 | 179 | 76 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 6.75e-07 | 181 | 76 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.97e-07 | 182 | 76 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 7.20e-07 | 183 | 76 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-07 | 183 | 76 | 6 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-07 | 183 | 76 | 6 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-07 | 184 | 76 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-07 | 184 | 76 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-07 | 184 | 76 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-07 | 184 | 76 | 6 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 7.67e-07 | 185 | 76 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-07 | 186 | 76 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.92e-07 | 186 | 76 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.92e-07 | 186 | 76 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.92e-07 | 186 | 76 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.17e-07 | 187 | 76 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.17e-07 | 187 | 76 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.43e-07 | 188 | 76 | 6 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 188 | 76 | 6 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 188 | 76 | 6 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-07 | 189 | 76 | 6 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-07 | 190 | 76 | 6 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-07 | 190 | 76 | 6 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-07 | 190 | 76 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.24e-07 | 191 | 76 | 6 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.24e-07 | 191 | 76 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.24e-07 | 191 | 76 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.24e-07 | 191 | 76 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-07 | 192 | 76 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-07 | 192 | 76 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.53e-07 | 192 | 76 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.53e-07 | 192 | 76 | 6 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 9.53e-07 | 192 | 76 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 9.82e-07 | 193 | 76 | 6 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.82e-07 | 193 | 76 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 9.82e-07 | 193 | 76 | 6 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-07 | 193 | 76 | 6 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.82e-07 | 193 | 76 | 6 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.82e-07 | 193 | 76 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-06 | 194 | 76 | 6 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 195 | 76 | 6 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 195 | 76 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.04e-06 | 195 | 76 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 76 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-06 | 196 | 76 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 76 | 6 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 76 | 6 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-06 | 196 | 76 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-06 | 196 | 76 | 6 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-06 | 196 | 76 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-06 | 197 | 76 | 6 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-06 | 198 | 76 | 6 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 198 | 76 | 6 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 199 | 76 | 6 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 199 | 76 | 6 | 4032f03a4165f5f2a90ef1d8315cc743ce9075bb | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.21e-06 | 200 | 76 | 6 | 8d75ce89393df452defacf2ec9a5bd4b7708afbb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PENK-L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.21e-06 | 200 | 76 | 6 | 08a00b0687bef5fef12bfa8e52ae4570071bae5e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.21e-06 | 200 | 76 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PENK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.21e-06 | 200 | 76 | 6 | 266990ee2e835e98b92dfdf7e3114f9737ffa85e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 200 | 76 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 200 | 76 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.12e-06 | 156 | 76 | 5 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-06 | 158 | 76 | 5 | b70b4dbcb0ee96d98578c14e89b1c3f74e84c517 | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 7.81e-06 | 159 | 76 | 5 | 4f670b57b8d3b090ea2f1aafe15baf93cb7ef146 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.05e-06 | 160 | 76 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.07e-06 | 164 | 76 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-06 | 165 | 76 | 5 | 2d01ae5d05fe55f6bebd53a5801c4c1f1544515c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.02e-05 | 168 | 76 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 168 | 76 | 5 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 168 | 76 | 5 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 168 | 76 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 168 | 76 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 169 | 76 | 5 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 170 | 76 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 175 | 76 | 5 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 176 | 76 | 5 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 177 | 76 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 177 | 76 | 5 | 4d67e24653caa318039870114849426ff2582e0c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 178 | 76 | 5 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 178 | 76 | 5 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 178 | 76 | 5 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 178 | 76 | 5 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 179 | 76 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-05 | 180 | 76 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-05 | 180 | 76 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-05 | 180 | 76 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 180 | 76 | 5 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| Drug | tegafur | 1.30e-08 | 49 | 75 | 6 | CID000005386 | |
| Drug | chondroitin sulfate | ADAMTS12 ADAMTS3 SEMA5B ADAMTS7 ADAMTS9 ADAMTS16 ADAMTS18 LTBP1 ADAMTS5 AGRN ADAMTSL4 | 1.06e-07 | 413 | 75 | 11 | CID000024766 |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.35e-06 | 200 | 75 | 7 | 3167_UP | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 1.07e-05 | 2 | 75 | 2 | CID000135804 | |
| Drug | funiferine N-oxide | 2.06e-05 | 49 | 75 | 4 | CID000191631 | |
| Drug | Dirian | 3.21e-05 | 3 | 75 | 2 | CID003034337 | |
| Drug | AC1NDNJY | 3.21e-05 | 3 | 75 | 2 | CID004578722 | |
| Drug | AC1O5U9L | 3.21e-05 | 3 | 75 | 2 | CID006440811 | |
| Disease | carpal tunnel syndrome | 2.48e-06 | 89 | 71 | 5 | EFO_0004143 | |
| Disease | glycerate measurement | 5.95e-06 | 15 | 71 | 3 | EFO_0021029 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.71e-05 | 3 | 71 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.83e-05 | 227 | 71 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | Weill-Marchesani syndrome | 3.41e-05 | 4 | 71 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 3.41e-05 | 4 | 71 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Geleophysic dysplasia | 5.68e-05 | 5 | 71 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 5.68e-05 | 5 | 71 | 2 | C0265287 | |
| Disease | central corneal thickness | 1.02e-04 | 309 | 71 | 6 | EFO_0005213 | |
| Disease | body fat distribution | 1.29e-04 | 202 | 71 | 5 | EFO_0004341 | |
| Disease | corneal topography | 1.41e-04 | 109 | 71 | 4 | EFO_0004345 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.58e-04 | 8 | 71 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | osteosarcoma | 1.58e-04 | 8 | 71 | 2 | EFO_0000637 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.18e-04 | 122 | 71 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | intraocular pressure measurement | 2.24e-04 | 509 | 71 | 7 | EFO_0004695 | |
| Disease | Colorectal Carcinoma | 2.80e-04 | 702 | 71 | 8 | C0009402 | |
| Disease | stenosing tenosynovitis | 3.71e-04 | 12 | 71 | 2 | EFO_0010822 | |
| Disease | tyrosine-protein kinase receptor Tie-1, soluble measurement | 4.38e-04 | 13 | 71 | 2 | EFO_0008312 | |
| Disease | Hypodontia | 5.10e-04 | 14 | 71 | 2 | C0020608 | |
| Disease | vital capacity | ADAMTS10 CACNA1S HMCN1 ADAMTS3 ADAMTS6 ADAMTS17 ADAMTS18 LTBP1 LTBP3 ADAMTSL3 | 7.25e-04 | 1236 | 71 | 10 | EFO_0004312 |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.29e-04 | 447 | 71 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | anthropometric measurement | 7.32e-04 | 168 | 71 | 4 | EFO_0004302 | |
| Disease | corneal resistance factor | 7.64e-04 | 451 | 71 | 6 | EFO_0010067 | |
| Disease | body weight | ADAMTS10 FBN2 ADAMTS3 ADAMTS17 LTBP1 LTBP3 THSD7B ADAMTS14 ADAMTSL3 PGK1 | 8.45e-04 | 1261 | 71 | 10 | EFO_0004338 |
| Disease | body surface area | 8.99e-04 | 643 | 71 | 7 | EFO_0022196 | |
| Disease | urinary albumin to creatinine ratio | 9.27e-04 | 179 | 71 | 4 | EFO_0007778 | |
| Disease | tooth agenesis | 1.28e-03 | 22 | 71 | 2 | EFO_0005410 | |
| Disease | cortical thickness | FBN2 ADAMTS3 ADAMTS7 ADAMTS9 WNT3A ADAMTS18 ADAMTS20 ADAMTSL3 STAB1 | 1.37e-03 | 1113 | 71 | 9 | EFO_0004840 |
| Disease | cortical surface area measurement | FBN2 MEGF6 ADAMTS3 ADAMTS7 EFS ADAMTS9 PDGFD ADAMTS18 ADAMTS20 ADAMTSL3 | 1.37e-03 | 1345 | 71 | 10 | EFO_0010736 |
| Disease | obesity (is_implicated_in) | 1.39e-03 | 91 | 71 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | lobe attachment | 1.58e-03 | 207 | 71 | 4 | EFO_0007667 | |
| Disease | osteoarthritis (is_implicated_in) | 2.07e-03 | 28 | 71 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.10e-03 | 105 | 71 | 3 | DOID:9352 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLGCACRWGGTTGTV | 251 | Q5H9S7 | |
| SWGGSLPDAQKCTCG | 711 | Q9BZ76 | |
| VGHSACSASCGKGVW | 671 | Q6UY14 | |
| WGSCSVTCGAGSQRR | 531 | O14514 | |
| WGQCSRSCGGGVQFA | 576 | Q9UNA0 | |
| GGTCQDWALGGGFTC | 1341 | O00468 | |
| CGRKGSGWVQCSKQD | 581 | O75078 | |
| WVKGQSAGGCRNNSG | 346 | Q9HC96 | |
| WGDCSRTCGGGVSSS | 556 | Q9H324 | |
| GNWSECSVSCGGGVR | 951 | P58397 | |
| GNWSKCSRNCSGGFK | 1371 | P58397 | |
| ATGNWDLCSTSCGGG | 1476 | P58397 | |
| SSWTKFGSCSRSCGG | 556 | Q8WXS8 | |
| WGACSRSCGKLGVQT | 916 | Q8WXS8 | |
| WSACSRTCGGGAQSR | 936 | Q8TE57 | |
| HSGWEGCSVQCGGGE | 806 | Q8TE56 | |
| SKWSECSRTCGGGVK | 596 | Q8TE60 | |
| NWGECSQTCGGGIKS | 1366 | P59510 | |
| LWGECSRTCGGGVSS | 566 | Q9UKP5 | |
| VDGTRCGENKWCLSG | 511 | Q9UKP4 | |
| WSKCSRSCGGGSSVR | 1471 | Q9UKP4 | |
| RGVCSDWRGATGGLC | 5341 | Q9HC84 | |
| IGGGDTATCCAKWNT | 371 | P07205 | |
| CCRGSGKSNVGTWGD | 71 | H3BUK9 | |
| CDWDGGDCSGNSGGS | 461 | Q3T906 | |
| GSLSWKRCAGCGGKI | 16 | P61968 | |
| GCGWCTDPSNTGKGK | 1001 | O75882 | |
| QGWAEGQGLGCRCSG | 421 | Q96I76 | |
| RCGGNCGCGTVNWRS | 301 | Q9GZP0 | |
| SKQEDCCGTVGTSWG | 576 | Q14766 | |
| ACPGCSTGGARSWKV | 81 | Q9BRP1 | |
| GGHSCVCVNGWTGES | 296 | Q9UM47 | |
| NCTSCLDSKGADGGW | 2066 | Q7Z7M0 | |
| WTACSRSCGGGVTSQ | 56 | Q86TH1 | |
| WGPCSGSCGQGRTIR | 746 | Q86TH1 | |
| SWAGSRQGSKECPGC | 156 | Q6X4W1 | |
| IGGGDTATCCAKWNT | 371 | P00558 | |
| PWGTCSESCGKGTQT | 4651 | Q96RW7 | |
| HSWSQCSASCGGGEK | 4821 | Q96RW7 | |
| GQGSCVALCTKGGYW | 196 | Q9Y2Y8 | |
| SWTKFGSCSRTCGTG | 556 | O15072 | |
| KCSGECNTGGWRYSA | 991 | Q9P2N4 | |
| PWGACSSTCAGGSQR | 1336 | Q9P2N4 | |
| WGECTKLCGGGIRTR | 1391 | Q9P2N4 | |
| RINGKWSGQSAGGCG | 691 | Q9Y6W3 | |
| GRRCTINGSECRGGW | 251 | Q13698 | |
| GCTDCGWGLARRGLA | 36 | P27544 | |
| QREGAGGLDGWCLCS | 36 | O43281 | |
| EDCCGSIGTAWGQSK | 301 | Q9NS15 | |
| TKSECCCDGGRGWGH | 2406 | P35556 | |
| TARCCGELWATGSKG | 201 | Q9NYQ7 | |
| GKGWRMDGGRTCSCS | 76 | Q9NZY2 | |
| WNADGSASCVRCGNG | 91 | Q96HA4 | |
| GSGCWSSVGNRRVGK | 121 | Q16820 | |
| RGLCRAWGGTCGAAL | 11 | Q9BQ95 | |
| SWGGSLPDAQKCTCG | 711 | Q96NU0 | |
| CKSCRNGSWGGTLDD | 91 | Q6UXH9 | |
| SNGSCSCGLGWTGRH | 1316 | O75095 | |
| TAWSECTKLCGGGIQ | 761 | Q9HCB6 | |
| CCRGSGKSNVGTWGD | 71 | A0A0A6YYL3 | |
| GLCTETGCRCDAGWT | 371 | Q9UK23 | |
| TGCRCDAGWTGSNCS | 376 | Q9UK23 | |
| CCRGSGKSNVGAWGD | 71 | P0CG39 | |
| KGECHCSTGWGGVNC | 641 | Q9UKZ4 | |
| SGGGCGSDWGCADTS | 51 | Q8TC41 | |
| WGCEGRRGSCGSTGS | 256 | Q92502 | |
| RWSGGSQTRCGKCVK | 101 | Q8N2B8 | |
| AGVTSWGTGCGQRNK | 526 | Q9BYE2 | |
| WVKDEGGDSCSGCSV | 3451 | Q8IZQ1 | |
| WAPCSASCGGGSQSR | 371 | O95428 | |
| GTWGLCSKSCSSGTR | 491 | O95428 | |
| CSCGSGWRGSQCQEA | 291 | P35590 | |
| CGGCGSCGDREWLRA | 186 | Q9BSE2 | |
| GGFCDCGDTEAWKTG | 146 | Q8IWV7 | |
| GDGSCVCNVGWQGLR | 1396 | Q9NY15 | |
| WSKCSSNCGGGMQSR | 731 | Q9P283 | |
| SLGEECWSLGQCGGV | 1386 | Q7Z7G8 | |
| CGCSSRHQGSPGKGW | 136 | P56704 | |
| SCGWCQKTPADGGSV | 271 | Q96DT7 | |
| LVSCGCGWKGSGEQD | 141 | O00744 | |
| LGNWSACKLEGGDCG | 1306 | Q9C0I4 | |
| CDSEWKGSQIGSCGT | 396 | O60294 | |
| WQGCLRKSCGIAGGD | 326 | Q6UX68 | |
| GCTCGSACGSWDVRA | 71 | Q9HD89 | |
| CFAWCRGSGKSNVGT | 31 | Q6S545 | |
| WCRGSGKSNVGTSGD | 71 | Q6S545 | |
| WCRGSGKSNVGTSGD | 71 | A6NI47 | |
| GDWSKCSVSCGVGIQ | 826 | P82987 |